{"id":"https://openalex.org/W12236136","doi":"https://doi.org/10.1055/s-0037-1613374","title":"Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial","display_name":"Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W12236136","doi":"https://doi.org/10.1055/s-0037-1613374","mag":"12236136","pmid":"https://pubmed.ncbi.nlm.nih.gov/12624628"},"language":"en","primary_location":{"id":"doi:10.1055/s-0037-1613374","doi":"https://doi.org/10.1055/s-0037-1613374","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1613374","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108077020","display_name":"Sara Quenet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sara Quenet","raw_affiliation_strings":["Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","Thrombosis Research Group, Clinical Pharmacological Department, University Hospital, Pavillon 5, F-42055 Saint-Etienne Cedex 2, France. silvy.laporte@chu-st-etienne.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]},{"raw_affiliation_string":"Thrombosis Research Group, Clinical Pharmacological Department, University Hospital, Pavillon 5, F-42055 Saint-Etienne Cedex 2, France. silvy.laporte@chu-st-etienne.fr","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055223385","display_name":"Andr\u00e9a Buchm\u00fcller-Cordier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Andr\u00e9a Buchm\u00fcller-Cordier","raw_affiliation_strings":["Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086237580","display_name":"Jacqueline Reynaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacqueline Reynaud","raw_affiliation_strings":["Departments of Haematology, Thrombosis Research Group, University Hospital Saint-Etienne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Haematology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033795461","display_name":"Brigitte Tardy-Poncet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Brigitte Tardy-Poncet","raw_affiliation_strings":["Departments of Haematology, Thrombosis Research Group, University Hospital Saint-Etienne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Haematology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023446111","display_name":"Christine Thirion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087076","display_name":"Stago (France)","ror":"https://ror.org/0014agb17","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210087076"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Thirion","raw_affiliation_strings":["Diagnostica Stago, Asni\u00e8res, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostica Stago, Asni\u00e8res, France","institution_ids":["https://openalex.org/I4210087076"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110031594","display_name":"Herv\u00e9 Decousus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Decousus","raw_affiliation_strings":["Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110164748","display_name":"Patrick Mismetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Mismetti","raw_affiliation_strings":["Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020949450","display_name":"Silvy Laporte","orcid":"https://orcid.org/0000-0001-6197-8668","observed_orcids":["https://orcid.org/0000-0001-6197-8668"]},"institutions":[{"id":"https://openalex.org/I4210157006","display_name":"Centre Hospitalier Universitaire de Saint-\u00c9tienne","ror":"https://ror.org/04pn6vp43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210157006"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Silvy Laporte","raw_affiliation_strings":["Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","Thrombosis Research Group, Clinical Pharmacological Department, University Hospital, Pavillon 5, F-42055 Saint-Etienne Cedex 2, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology, Thrombosis Research Group, University Hospital Saint-Etienne, France","institution_ids":["https://openalex.org/I4210157006"]},{"raw_affiliation_string":"Thrombosis Research Group, Clinical Pharmacological Department, University Hospital, Pavillon 5, F-42055 Saint-Etienne Cedex 2, France","institution_ids":["https://openalex.org/I4210157006"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020949450"],"corresponding_institution_ids":["https://openalex.org/I4210157006"],"apc_list":null,"apc_paid":null,"fwci":1.9508,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.86938406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"89","issue":"03","first_page":"458","last_page":"467"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.9160000085830688},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.8600000143051147},{"id":"https://openalex.org/keywords/acenocoumarol","display_name":"acenocoumarol","score":1.0},{"id":"https://openalex.org/keywords/anticoagulation-stability","display_name":"anticoagulation stability","score":0.6620000004768372},{"id":"https://openalex.org/keywords/inr-variability","display_name":"INR variability","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6769999861717224},{"id":"https://openalex.org/keywords/patient-education","display_name":"patient education","score":0.9509999752044678},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8550000190734863},{"id":"https://openalex.org/keywords/dose-determination","display_name":"dose determination","score":0.6230000257492065},{"id":"https://openalex.org/keywords/anticoagulation-management","display_name":"anticoagulation management","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2781344064","wikidata":"https://www.wikidata.org/wiki/Q304088","display_name":"Acenocoumarol","level":4,"score":0.9697622656822205},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8274705410003662},{"id":"https://openalex.org/C2992750412","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Oral anticoagulant","level":4,"score":0.6658607721328735},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.6259225606918335},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.5398887991905212},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44999635219573975},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.42345431447029114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4039233922958374},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33825600147247314},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.17275506258010864}],"mesh":[{"descriptor_ui":"D000074","descriptor_name":"Acenocoumarol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000074","descriptor_name":"Acenocoumarol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019934","descriptor_name":"International Normalized Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-0037-1613374","doi":"https://doi.org/10.1055/s-0037-1613374","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0037-1613374","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:12624628","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12624628","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322807","display_name":"Minist\u00e8re de la Sant\u00e9","ror":"https://ror.org/00yrwkd81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W77437304","https://openalex.org/W86438867","https://openalex.org/W1586488555","https://openalex.org/W1591542275","https://openalex.org/W1882292014","https://openalex.org/W1987381409","https://openalex.org/W1994894525","https://openalex.org/W2004337162","https://openalex.org/W2030634113","https://openalex.org/W2038146269","https://openalex.org/W2046208376","https://openalex.org/W2052333331","https://openalex.org/W2116615243","https://openalex.org/W2125650394","https://openalex.org/W2137354881","https://openalex.org/W2157455042","https://openalex.org/W2160781070","https://openalex.org/W2326914415","https://openalex.org/W2569198352","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2038146269","https://openalex.org/W2074808806","https://openalex.org/W2409699785","https://openalex.org/W1983313884","https://openalex.org/W2151274024","https://openalex.org/W1882292014","https://openalex.org/W6980225247","https://openalex.org/W2145270868","https://openalex.org/W185000239","https://openalex.org/W2017768179"],"abstract_inverted_index":{"The":[0],"aim":[1],"of":[2,11,14,16,24,26,60,69,89],"the":[3,8,12,67,72,75,79,99,116,124,137],"study":[4],"was":[5,64,85,103,121],"to":[6,38,55,142],"assess":[7],"respective":[9],"roles":[10],"half-life":[13],"elimination":[15],"oral":[17,32,61,130],"anticoagulants":[18],"and":[19,48,71,78,110],"patient":[20],"education":[21,125],"as":[22],"causes":[23],"instability":[25,102,111],"anticoagulation":[27],"level":[28],"in":[29,115],"patients":[30,94,128],"on":[31],"anticoagulant":[33,62,131],"therapy.":[34],"Patients":[35],"were":[36,95,112],"randomised":[37],"receive":[39],"either":[40,49],"warfarin":[41],"(long":[42],"half-life)":[43,47],"or":[44,51],"acenocoumarol":[45,117],"(short":[46],"intensive":[50],"standard":[52],"education,":[53],"according":[54],"a":[56],"factorial":[57],"design.":[58],"Instability":[59],"therapy":[63],"evaluated":[65],"by":[66,87],"percentage":[68],"INRs":[70],"time":[73],"within":[74],"target":[76],"range,":[77],"variability":[80,100],"between":[81,105,108,123],"successive":[82],"measurements.":[83],"Compliance":[84],"assessed":[86],"means":[88],"electronic":[90],"pill":[91],"bottles.":[92],"Eighty-six":[93],"included.":[96],"Apart":[97],"from":[98],"index,":[101],"similar":[104],"groups.":[106,126],"Correlations":[107],"compliance":[109],"observed":[113],"only":[114],"group.":[118],"No":[119],"difference":[120],"found":[122],"In":[127],"starting":[129],"therapy,":[132],"dose":[133],"determination":[134],"may":[135],"be":[136],"most":[138],"important":[139],"factor":[140],"contributing":[141],"instability.":[143]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}